Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04256395
Other study ID # RWS-BTCH-002
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2020
Est. completion date July 1, 2020

Study information

Verified date July 2020
Source Beijing Tsinghua Chang Gung Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The "COVID-19 infection self-test and alert system" (hereinafter referred to as "COVID-19 self-test applet") jointly developed by Beijing Tsinghua Changgung Hospital, Institute for precision medicine, artificial intelligence of Tsinghua University was launched on February 1,2020. Residents , according to their actual healthy situation, after answering questions online, the system will conduct intelligent analysis, make disease risk assessment and give healthcare and medical guidance. Based on the Internet population survey, and referring to the diagnosis and screening standards of the National Health Commission of the People's Republic of China, investigators carried out the mobile applet of Internet survey and registry study for the Internet accessible identifiable population, so as to screen the suspected population and guide the medical treatment.


Description:

The "COVID-19 infection self-test and alert system" (hereinafter referred to as "COVID-19 self-test applet") jointly developed by Beijing Tsinghua Changgung Hospital, Institute for precision medicine, artificial intelligence of Tsinghua University was launched on February 1,2020. This survey was also advocated by Chinese Medical Doctor Association. Residents , or even oversea Chinese people,according to their actual healthy situation, after answering questions online, the system will conduct intelligent analysis, make disease risk assessment and give healthcare and medical guidance. Based on the Internet population survey, and referring to the diagnosis and screening standards of the National Health Commission of the People's Republic of China, investigators carried out the mobile applet of Internet survey and registry study for the Internet accessible identifiable population, so as to screen the suspected population and guide the medical treatment.


Recruitment information / eligibility

Status Completed
Enrollment 102456
Est. completion date July 1, 2020
Est. primary completion date July 1, 2020
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- people who lived in or out of China at present and threatened by the infection and spread of COVID-19

- without gender and age restriction

- people who have concerns of his health

- voluntary completion of the self-test and evaluation.

Exclusion Criteria:

- people who are not internet accessible or can not use this Mobile Applet.

- people who can not recognize the questionnaire.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
mobile internet survey on self-test
1. make a questionnaire, the content of which refers to the new coronavirus diagnosis and treatment guidelines released by the National Health Commission; 2. develop the mobile applet and carry out internet propagation; 3. background data could be identified according to computer technology, de duplication and de privacy; 4. once registered, the applet can automatically remind the self-test twice a day, and encourage to adhere to 14 days; 5. automatically compare with the standards and highly suspected population could be given medical guidance and encouraged to go to the fever clinic of the designated hospital for definite diagnosis.

Locations

Country Name City State
China Beijing Tsinghua Changgung Hospital Beijing Beijing

Sponsors (6)

Lead Sponsor Collaborator
Beijing Tsinghua Chang Gung Hospital Chinese Medical Doctor Association, Institute for artificial intelligent of Tsinghua University, Institute for network behavior of Tsinghua University, Institute for precision medicine of Tsinghua University, school of clinical medicine of Tsinghua University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary positive number diagnosed by national guideline in the evaluated population after the end of this study, investigators calculate and sum up the total evaluated population and positively diagnosed population, then check the ROC of this system, finally to calculate the sensitivity and accuracy of this self-test and self-alert system 5 months
Secondary distribution map of evaluated people after the end of this study, investigators calculate the proportion and distribution of evaluated people with normal and abnormal scores 5 month
Secondary Effect of medical guidance by designated feedback questionnaire after the end of this study, investigators sent the feedback inform to every evaluated people and collect and analysis the response to find out whether this applet can help them in the following surveillance or medical treatment. And how it works. 5 month
Secondary mental scale of relief the mental anxiety and avoid unnecessary outpatient after the end of this study, investigators sent the designated mental scale including anxiety, and collect the response and draw the conclusion. 5 month